Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 25412 | 234 | 29.6 | 74% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1446 | 7310 | LEVOSIMENDAN//CALCIUM SENSITIZERS//CALCIUM SENSITIZER |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TSC 22 | Author keyword | 77 | 96% | 10% | 24 |
| 2 | VESNARINONE | Author keyword | 58 | 73% | 19% | 45 |
| 3 | POSITIVE INOTROPIC ACTIVITY | Author keyword | 14 | 60% | 6% | 15 |
| 4 | 1 2 4TRIAZOLO4 3 AQUINOLINES | Author keyword | 4 | 67% | 2% | 4 |
| 5 | BUNCHED | Author keyword | 4 | 75% | 1% | 3 |
| 6 | QUINOLINONE DERIVATIVE | Author keyword | 4 | 75% | 1% | 3 |
| 7 | OPC 8212 | Author keyword | 3 | 100% | 1% | 3 |
| 8 | NAT OURCES FUNCT MOL CHANGBAI MT | Address | 2 | 22% | 4% | 9 |
| 9 | TETRAZOLO5 1 APHTHALAZINE | Author keyword | 2 | 67% | 1% | 2 |
| 10 | 1 4 DIAZEPANE | Author keyword | 2 | 40% | 2% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | TSC 22 | 77 | 96% | 10% | 24 | Search TSC+22 | Search TSC+22 |
| 2 | VESNARINONE | 58 | 73% | 19% | 45 | Search VESNARINONE | Search VESNARINONE |
| 3 | POSITIVE INOTROPIC ACTIVITY | 14 | 60% | 6% | 15 | Search POSITIVE+INOTROPIC+ACTIVITY | Search POSITIVE+INOTROPIC+ACTIVITY |
| 4 | 1 2 4TRIAZOLO4 3 AQUINOLINES | 4 | 67% | 2% | 4 | Search 1+2+4TRIAZOLO4+3+AQUINOLINES | Search 1+2+4TRIAZOLO4+3+AQUINOLINES |
| 5 | BUNCHED | 4 | 75% | 1% | 3 | Search BUNCHED | Search BUNCHED |
| 6 | QUINOLINONE DERIVATIVE | 4 | 75% | 1% | 3 | Search QUINOLINONE+DERIVATIVE | Search QUINOLINONE+DERIVATIVE |
| 7 | OPC 8212 | 3 | 100% | 1% | 3 | Search OPC+8212 | Search OPC+8212 |
| 8 | TETRAZOLO5 1 APHTHALAZINE | 2 | 67% | 1% | 2 | Search TETRAZOLO5+1+APHTHALAZINE | Search TETRAZOLO5+1+APHTHALAZINE |
| 9 | 1 4 DIAZEPANE | 2 | 40% | 2% | 4 | Search 1+4+DIAZEPANE | Search 1+4+DIAZEPANE |
| 10 | 1 2 4TRIAZOLO3 4 APHTHALAZINE | 1 | 100% | 1% | 2 | Search 1+2+4TRIAZOLO3+4+APHTHALAZINE | Search 1+2+4TRIAZOLO3+4+APHTHALAZINE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BETA STIMULATED CLONE 22 | 25 | 70% | 9% | 21 |
| 2 | GLAND CANCER CELL | 24 | 82% | 6% | 14 |
| 3 | 3 4 DIHYDRO 6 4 3 4 DIMETHOXYBENZOYL 1 PIPERAZINYL 21H QUINOLINONE VESNARI | 17 | 100% | 3% | 8 |
| 4 | OPC 8212 | 16 | 56% | 8% | 19 |
| 5 | STIMULATED CLONE 22 | 13 | 80% | 3% | 8 |
| 6 | LEY ANTIGEN EXPRESSION | 11 | 100% | 3% | 6 |
| 7 | TSC 22 | 6 | 53% | 3% | 8 |
| 8 | INOTROPIC AGENT | 5 | 25% | 8% | 19 |
| 9 | POSITIVE INOTROPIC AGENT | 5 | 28% | 6% | 14 |
| 10 | VESNARINONE | 3 | 22% | 6% | 14 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Differentiation-inducing therapy for solid tumors | 2006 | 34 | 77 | 56% |
| TSC-22 (TGF-beta stimulated clone-22): A novel molecular target for differentiation-inducing therapy in salivary gland cancer | 2004 | 13 | 36 | 64% |
| Vesnarinone: a differentiation-inducing anti-cancer drug | 2003 | 3 | 50 | 86% |
| The Progress Towards the Development of DHQO Derivatives and Related Analogues with Inotropic Effects | 2013 | 0 | 48 | 52% |
| Precautions for use and adverse effects of vesnarinone - Potential mechanisms and future therapies | 2004 | 0 | 20 | 65% |
| Clinical characteristics of vesnarinone | 2004 | 0 | 26 | 62% |
| PHARMACOLOGICAL PROPERTIES AND CLINICAL-EVALUATION OF THE NEW INOTROPIC AGENT OPC-8212 (VESNARINONE) | 1993 | 6 | 33 | 64% |
| Update on digoxin and other oral positive inotropic agents for chronic heart failure | 1997 | 12 | 38 | 16% |
| Inotropic effects of DN-9693: A selective cyclic AMP phosphodiesterase inhibitor | 1996 | 0 | 21 | 19% |
| CYCLIC-AMP-DEPENDENT POSITIVE CHRONOTROPIC AND INOTROPIC RESPONSES IN THE BLOOD-PERFUSED DOG ATRIUM | 1992 | 1 | 18 | 11% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NAT OURCES FUNCT MOL CHANGBAI MT | 2 | 22% | 3.8% | 9 |
| 2 | AFFILIATED MINIST EDUC | 1 | 18% | 3.0% | 7 |
| 3 | MED INTERNAL MED 3 SAKYO KU | 1 | 50% | 0.9% | 2 |
| 4 | CELLULAR THER HY | 1 | 50% | 0.4% | 1 |
| 5 | CHANGBAI MT NAT OURCES FUNCT MOL | 1 | 50% | 0.4% | 1 |
| 6 | CLIN PHARMACOKINET METAB | 1 | 50% | 0.4% | 1 |
| 7 | PHARMACOKINET PHASE DEV 1 | 1 | 50% | 0.4% | 1 |
| 8 | PULM CARDIOL | 1 | 50% | 0.4% | 1 |
| 9 | ORAL SURG HLTH BIOSCI | 0 | 33% | 0.4% | 1 |
| 10 | SUB MOL ORAL MED | 0 | 33% | 0.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000202908 | ENOXIMONE//AMRINONE//MILRINONE |
| 2 | 0.0000133948 | MOUSE LYMPHOID NEOPLASMA P 388//MOUSE MAMMARY CARCINOMA FM 3A//HUMAN HISTIOCYTIC LYMPHOMA U 937 |
| 3 | 0.0000114911 | LEVOSIMENDAN//CALCIUM SENSITIZERS//CALCIUM SENSITIZER |
| 4 | 0.0000086140 | WINTERS HEART FAILURE//CARDIAC CACHEXIA//PL CACHEXIA |
| 5 | 0.0000075975 | BDF 9148//DPI 201 106//NA CHANNEL MODULATORS |
| 6 | 0.0000065954 | IBOPAMINE//EPININE//NOLOMIROLE |
| 7 | 0.0000064457 | DUBOWITZ SYNDROME//CERVICAL SPINE ABNORMALITIES//CHEM S MINAMI KU |
| 8 | 0.0000043926 | AGRANULOCYTOSIS//DRUG INDUCED AGRANULOCYTOSIS//EVALUATION SCORE |
| 9 | 0.0000039811 | AZAPEROL//CONFIRMATORY METHODS//CARAZOLOL |
| 10 | 0.0000039360 | SOAPFISH//GRAMMISTIN//PARDAXIN |